Seroatlas · Human Serome Atlas

B3GAT1

Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1

Also known as: B3GA1_HUMAN, CD57, GlcAT-P, HNK-1, LEU7, NK-1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9P2W7
Gene
B3GAT1
Ensembl
ENSG00000109956
Chromosome
11
Canonical length
334 aa
Protein class
Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins
Subcellular location
Vesicles
Secretome location
Secreted in brain
Quaternary structure
Homodimer

OverviewNCBI Gene

The protein encoded by this gene is a member of the glucuronyltransferase gene family. These enzymes exhibit strict acceptor specificity, recognizing nonreducing terminal sugars and their anomeric linkages. This gene product functions as the key enzyme in a glucuronyl transfer reaction during the biosynthesis of the carbohydrate epitope HNK-1 (human natural killer-1, also known as CD57 and LEU7). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

334 residues, UniProt reviewed canonical sequence.

>Q9P2W7|B3GAT1
     1  MPKRRDILAI VLIVLPWTLL ITVWHQSTLA PLLAVHKDEG SDPRRETPPG ADPREYCTSD
    61  RDIVEVVRTE YVYTRPPPWS DTLPTIHVVT PTYSRPVQKA ELTRMANTLL HVPNLHWLVV
   121  EDAPRRTPLT ARLLRDTGLN YTHLHVETPR NYKLRGDARD PRIPRGTMQR NLALRWLRET
   181  FPRNSSQPGV VYFADDDNTY SLELFEEMRS TRRVSVWPVA FVGGLRYEAP RVNGAGKVVG
   241  WKTVFDPHRP FAIDMAGFAV NLRLILQRSQ AYFKLRGVKG GYQESSLLRE LVTLNDLEPK
   301  AANCTKILVW HTRTEKPVLV NEGKKGFTDP SVEI

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against B3GAT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.36
Highest tissue expression
191 nTPM

Expression across tissuesHPA

Tissue

  • spinal cord: 191 nTPM
  • hippocampal formation: 178 nTPM
  • amygdala: 150 nTPM
  • cerebral cortex: 149 nTPM
  • midbrain: 97 nTPM
  • basal ganglia: 90 nTPM

Single-cell type

  • müller glia: 145 nCPM
  • oligodendrocytes: 121 nCPM
  • oligodendrocyte progenitor cells: 74 nCPM
  • brain excitatory neurons: 53 nCPM
  • bergmann glia: 52 nCPM
  • gastric chief cells: 46 nCPM

Immune cell

  • gdT-cell: 1.1 nTPM
  • memory CD8 T-cell: 0.6 nTPM
  • naive CD8 T-cell: 0.6 nTPM
  • memory CD4 T-cell: 0.2 nTPM
  • total PBMC: 0.1 nTPM
  • basophil: 0 nTPM

Brain region

  • cerebral cortex: 354 nTPM
  • hippocampal formation: 351 nTPM
  • white matter: 305 nTPM
  • amygdala: 255 nTPM
  • midbrain: 254 nTPM
  • medulla oblongata: 231 nTPM

ReferencesPubMed · IEDB

Publications for B3GAT1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Reference: AutoantibodyPubMed

11 publications

Show 6 more

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.64
gnomAD pLI
0.14
gnomAD missense Z
2.42
DepMap mean gene effect
0.05
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of B3GAT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads B3GAT1 as an antibody target. Whether an autoantibody or antibody against B3GAT1 could matter depends on whether native B3GAT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

B3GAT1 is annotated as secreted, so native B3GAT1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label B3GAT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/B3GAT1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...